Plasma Therapy Market Size, Share, Trends, Growth 2032

Plasma Therapy Market Insights

According to a report from Zion Market Research, the global Plasma Therapy Market was valued at USD 381.4 Million in 2023 and is projected to hit USD 1265.25 Million by 2032, with a compound annual growth rate (CAGR) of 12.7% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Plasma Therapy Market industry over the next decade.

Request Free Sample

Plasma Therapy Market: Outlook

In Plasma therapy, the plasma of a healthy individual who has recovered from a disease is transmitted to a patient suffering from the same ailment, the reason being the plasma of the former possesses a huge proportion of antibodies. Recently, convalescent plasma treatment has been used for treating COVID-19 patients across the globe. Moreover, this treatment has been used for a long period in fields such as orthopedic, dentistry, and dermatology. Apparently, plasma therapy finds extensive application in facial restoration, wound healing, cardiac muscle damage, and androgenetic alopecia.

Request Free Sample

Plasma Therapy Market: Growth Drivers

The surge in the number of androgenic alopecia patients across the globe has generated a massive need for plasma therapy in recent years. In addition to this, the escalating requirement for painless as well as minimally invasive procedures will drive plasma therapy industry trends. Apart from this, the immense requirement for prompting long-time healing of musculoskeletal conditions will accentuate the growth of the plasma therapy market in the years ahead.

Furthermore, the surge in the use of plasma therapy in a wide number of therapeutic fields will create new growth avenues for the plasma therapy industry. An increase in the size of the plasma therapy market over the forecast timespan can also be credited to a prominent increase in cases of arthritis in years ahead.

Furthermore, a rise in awareness about the effectiveness and therapeutic use of plasma therapy for patients suffering from chronic ailments is predicted to add to the profitability of the plasma therapy market. However, less use of plasma therapy for treating diabetics as well as other kidney disorders will pose a challenge to the expansion of the plasma therapy market in the upcoming years. Additionally, the dearth of favorable compensation policies and fluctuating costs of plasma therapy can hinder the progress of the market in the ensuing years.

Plasma Therapy Market: Report Scope

Plasma Therapy Market: Regional Landscape

North America To Lead Overall Market Growth By 2032

Expansion of the plasma therapy market in North America over 2024-2032 can be credited to an increase in the number of plasma donors in Countries such as Canada and the U.S. Apart from this, rise in funding of research activities pertaining to plasma therapy by governments in Canada and the U.S. will promulgate scope of regional market. In addition to this, the use of new protein fractioning methods will boost the elevation of plasma therapy industry revenue in North America in forthcoming years. The presence of giant players in the region will account for major regional market share in the upcoming timespan.

Plasma Therapy Market: Competitive Landscape

Some of these key participants in our market research report and they are

• CambrynBiologics LLC
• China Biologic Products, Inc
• Kedrion S.p.A
• BioLife Plasma Services
• CSL Limited
• Grifols International S.A.
• LFB S.A.
• Bio Products Laboratory Ltd
• Octapharma

The global Plasma Therapy Market is segmented as follows:

By End-User

• Hospitals & Clinics
• Research Institutes

By Source

• Autologous
• Allogenic

By Application

• Orthopedic
• Dermatology
• Cardiac Muscle Injury
• Dental
• Nerve Injury

By Type

• Pure PRP
• Leukocyte-Rich Fibrin
• Pure Platelet-Rich Fibrin
• Leukocyte-Rich Fibrin

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa